Drug Shortage Report for TYPHERIX

Last updated on 2020-02-27 History
Report ID 2737
Drug Identification Number 02242727
Brand name TYPHERIX
Common or Proper name SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE
Company Name GLAXOSMITHKLINE INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE
Strength(s) 25MCG
Dosage form(s) LIQUID
Route of administration INTRAMUSCULAR
Packaging size 1's
ATC code J07AP
ATC description BACTERIAL VACCINES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-05-05
Estimated end date
Actual end date 2017-12-21
Shortage status Resolved
Updated date 2020-02-27
Company comments This product has been discontinued.
Health Canada comments
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2020-02-27 French Compare
v7 2020-02-27 English Compare
v6 2017-12-22 French Compare
v5 2017-12-22 English Compare
v4 2017-10-04 French Compare
v3 2017-10-04 English Compare
v2 2017-03-14 French Compare
v1 2017-03-14 English Compare